the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |
 

* View All Categories
Japanese Korean

[Report]

Strategic Perspectives 2001: Obsessive Compulsive Disorder - A Developed Market Still Attracting New Entrant

Published: 2001/08

Contact 24 hrs/day
Table of Contents

ANXIETY DISORDERS - NEW OPPORTUNITIES FOR GROWTH

In the past, anxiolytic medications such as the benzodiazepines have been the gold standard treatment of anxiety, despite the poor side effect profile and addiction problem associated with this class of drugs. However, since the launch of the serotonergic class of antidepressants, led by Lilly's Prozac, anxiety markets have been targeted by manufacturers of modern antidepressants as a method of extending the patient potential of their products. Consequently, these drugs have replaced the old anxiolytics as the gold standard therapy in many anxiety markets. This is due to a number of factors: .

* A high level of comorbidity exists between psychiatric disorders .

* Physicians focus on treating the symptoms of the disorders which often overlap .

* Antidepressant manufacturers are seeking other markets into which to move their products to maintain their growth

Therefore, anxiety markets have become the new battleground for antidepressants. In a race to differentiate themselves from rival products, manufacturers are continuously enhancing their position within niche sectors of the anxiety arena.

Although the majority of major anxiety markets are now highly competitive, the current lack of effective opposition from anxiolytics presents a key opportunity for antidepressant manufacturers to achieve substantial market uptake in numerous key anxiety markets.

REPORT SERIES OVERVIEW

Datamonitor's Strategic Perspectives 2001:

Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an indepth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder. Anxiety Disorders covered: .

* Eating Disorders (Anorexia Nervosa and Bulimia Nervosa) .
* Generalized Anxiety Disorder .
* Obsessive Compulsive Disorder .
* Panic Disorder .
* Phobias (Specific Phobia and Agoraphobia) .
* Post Traumatic Stress Disorder .
* Premenstrual Dysphoric Disorder .
* Social Anxiety Disorder

Table of Contents

[Report]
Strategic Perspectives 2001: Obsessive Compulsive Disorder - A Developed Market Still Attracting New Entrant
Published: 2001/08
Published by : Datamonitor Datamonitor

US $ 3,800.00 PDF by E-mail (Single User License)
US $ 9,500.00 PDF by E-mail (Global License)
>
Product Code : DC8617
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.